Abstract
Nutrien Ltd. will report quarterly results on August 5, 2026 Post Market; this preview outlines consensus expectations for revenue, profitability and EPS, reviews last quarter’s metrics and segment mix, and compiles dominant sell-side views to frame the stock’s near-term setup.Market Forecast
Consensus projects Nutrien Ltd.’s current quarter revenue at 10.40 billion US dollars, down 1.19% year over year, with adjusted EPS at 2.74, up 12.79% year over year, and EBIT at 1.93 billion US dollars, up 9.19% year over year. Forecasts do not provide a gross profit margin or net profit/net margin for this quarter; commentary centers on price and cost transmission to earnings rather than margin targets.Within the company’s revenue mix last quarter, crop inputs retail remained the anchor at 3.64 billion US dollars, complemented by 1.13 billion US dollars from nitrogen, 1.04 billion US dollars from potash, and 547.00 million US dollars from phosphate (partially offset by -391.00 million US dollars in eliminations). The segment with the clearest near-term rebound potential remains nitrogen, which delivered 1.13 billion US dollars last quarter; year-over-year growth for this specific segment was not disclosed in public consensus, but analysts highlight improving price realization as the key tailwind.
Last Quarter Review
Nutrien Ltd.’s prior quarter delivered revenue of 5.80 billion US dollars, up 19.04% year over year, with a gross profit margin of 28.37%, GAAP net profit attributable to shareholders of 131.00 million US dollars, a net profit margin of 2.26%, and adjusted EPS of 0.51, up 363.64% year over year. Revenue topped consensus by 0.53 billion US dollars, while adjusted EPS was marginally below expectations by 0.01.Operationally, the quarter’s revenue strength reflected a broad-based contribution from the retail network and the core nutrient franchises. Retail generated 3.64 billion US dollars, nitrogen 1.13 billion US dollars, potash 1.04 billion US dollars, and phosphate 547.00 million US dollars; year-over-year segment growth rates were not specified in the reported mix.
Current Quarter Outlook
Main business: Retail revenue and margin translation
For this quarter, the retail network remains central to the earnings bridge from revenue to EPS. The prior quarter showed retail revenue at 3.64 billion US dollars, setting a higher baseline for product volumes and services revenue into the key application period. The quarter’s consensus points to a revenue decline at the consolidated level, but the mix still leans on retail’s breadth in crop nutrients, crop protection, seed, agronomy and application services, which together provide a partial buffer against single-product pricing swings. The critical factor to watch is operating leverage in retail: recent sequential growth in consolidated revenue and a relatively modest GAAP net margin last quarter imply that incremental gross profit conversion and expense discipline at the retail layer will be highly consequential to hitting the 2.74 adjusted EPS estimate.Pricing, rebates and product mix will shape retail margins. On the pricing side, normalization in certain input categories can reduce ticket sizes but may be offset by improved unit throughput as growers recalibrate input plans. Mix matters as a higher share of proprietary or value-added services can support gross margin stability relative to pure commodity pass-through. From a cost standpoint, logistics and working capital intensity typically tighten into mid-year; any easing in freight or distribution friction compared with the same period last year can lift gross-to-operating margin translation.
Cash conversion within retail is another focus this quarter. The last quarter’s GAAP net margin of 2.26% and the consensus call for an EPS rebound to 2.74 imply significant second-quarter working capital release and margin uplift are embedded in expectations. Inventory turns and collections cadence around the seasonal peak drive operating cash flow; better turns and disciplined credit can meaningfully support EBIT delivery even if consolidated revenue is slightly lower year over year. In short, if retail sustains volume momentum while maintaining pricing and cost control, the pathway to the projected EPS and EBIT becomes clearer despite the revenue headwind.
Most promising business: Nitrogen profitability and cost tailwinds
Nitrogen contributed 1.13 billion US dollars last quarter and is widely viewed by analysts as the most levered near-term margin driver due to realized price trends and an advantaged cost base. The current quarter’s EBIT forecast of 1.93 billion US dollars, up 9.19% year over year, embeds improved unit margins in nitrogen relative to early 2025/2026 troughs. The key to upside is realized ammonia/urea/UAN pricing translating to higher gross profit per ton, coupled with stable or comparatively lower feedstock gas costs in North America. Where realized prices have firmed, incremental margin fall-through can be substantial given high fixed-cost absorption in the ammonia chain.Cost competitiveness is central. The economics of nitrogen are sensitive to natural gas input costs, and a stable North American gas cost environment can preserve an absolute cost advantage. If realized selling prices have risen faster than input costs, unit margins expand, supporting consolidated gross margin even if other nutrients track more normal seasonal pricing. Operationally, plant reliability and run-rate utilization also matter; sustained high operating rates spread fixed costs and improve throughput economics, supporting the consensus EPS and EBIT trajectory. The segment’s contribution is also amplified by the integrated downstream channel through retail: capturing more of the value chain can reduce volatility and support better realized netbacks.
Risk-management around forward sales and gas hedging/risk practices will influence margin volatility in the reported period. If a significant portion of sales was pre-committed at favorable netbacks while feedstock was secured at stable rates, reported margins should be resilient. Conversely, any mismatch between price realization and input costs could cap the upside implied by the 12.79% year-over-year growth in adjusted EPS. Given the forecast revenue decline at the consolidated level, nitrogen’s incremental margin dollars are a pivotal swing factor for overall profitability and cash generation this quarter.
What will most impact the stock this quarter
Three levers stand out for share price reaction on results day. First, margin quality relative to revenue: with consensus pointing to a 1.19% year-over-year decline in revenue but a 12.79% year-over-year increase in adjusted EPS, investors will scrutinize gross-to-operating margin flow-through. A print that confirms stronger realized margins in nitrogen and stable retail operating margins would support the EPS beat/meet narrative even if revenue is in line or modestly light. Second, cash flow and balance sheet posture: recent financing activity included 1.00 billion US dollars in senior notes, indicating a proactive approach to the maturity ladder and liquidity. If operating cash flow and free cash flow trajectories are reiterated or improved, sentiment on capital returns could inflect positively.Third, forward commentary on pricing and capital allocation will guide post-print performance. Any update on expected price realization for the second half, planned maintenance, or unit capacity utilization will inform durability of the 1.93 billion US dollars EBIT run-rate. In parallel, commentary on capital deployment—whether toward deleveraging, buybacks, or selective growth spending—will shape how investors translate near-term profit into valuation. Given the consensus pattern of bullish ratings from multiple institutions and a smaller cohort of cautious views, management’s tone on visibility and discipline could either validate the bullish skew or give weight to the minority cautious stance.
Analyst Opinions
Across the past six months, the balance of opinions has been predominantly bullish. Counting only directional calls, Buy/Outperform recommendations from RBC Capital Markets, Wells Fargo, Barclays, Morgan Stanley, CIBC, National Bank, Raymond James, and Scotiabank outnumber explicit bearish views such as UBS’s Sell and isolated downgrades to Hold. The ratio of bullish to bearish views is roughly 8:1 when focusing on Buy/Outperform versus Sell ratings, with a handful of Hold ratings as neutral.Several well-known institutions outline the bull case with specifics that map directly to the quarter’s consensus. RBC Capital Markets expects solid execution, improved cash generation in 2026 and 2027, and near-term support from higher nitrogen prices, while also noting steady demand for other nutrients and healthy planted acreage that sustains retail throughput. Wells Fargo and Barclays have reiterated Buy ratings within the period, effectively endorsing the view that realized prices and mix can lift profitability even if consolidated revenue is not at a peak. Raymond James upgraded the shares to Outperform and raised its price target to 90 US dollars, reflecting confidence that earnings power is recovering and that the stock’s prior drawdown created a more attractive entry point for a margin-led rebound. Scotiabank, raising its rating to sector outperform, echoes the improving earnings quality thesis tied to better pricing and expected cash flow resilience.
The bullish side emphasizes three transmitters from operations to valuation in this quarter. First is the uplift in adjusted EPS to 2.74, up 12.79% year over year, which is seen as credible provided nitrogen margins continue to firm and retail maintains stable conversion of gross profit to EBIT. Second is the consensus EBIT of 1.93 billion US dollars, up 9.19% year over year; institutions argue this EBIT inflection provides a stronger foundation for free cash flow, particularly if working capital releases standardize into the second half. Third is capital discipline: the recent 1.00 billion US dollars note issuance is viewed as a balance-sheet management step that preserves flexibility while de-risking the maturity schedule, enabling ongoing shareholder returns when cash generation normalizes.
Bullish analysts also point to the revenue mix as a structural positive into the print. With retail accounting for 3.64 billion US dollars last quarter and nitrogen at 1.13 billion US dollars, the company’s channel integration provides a partial hedge against input price swings and supports better netbacks compared with a standalone nutrient producer. If this integration again shows up as improved gross margin dollars despite a revenue line that is forecast 1.19% lower year over year, it would validate the bull thesis that the earnings base has decoupled from revenue volatility to some degree, driven by mix and cost discipline. This logic is consistent with the way the EPS consensus rises year over year in the face of a modest top-line decline.
Finally, bullish institutions note that last quarter’s pattern—0.53 billion US dollars revenue beat and a de minimis adjusted EPS miss—suggested top-line momentum was returning faster than profits, but that the profit gap should close as pricing resets flow through with a lag and cost normalization continues. If the company now converts that revenue strength into the projected 2.74 adjusted EPS and 1.93 billion US dollars EBIT, the intra-year trajectory would demonstrate the margin elasticity that these institutions have been underwriting. In this framing, the surprise factor on results day is likely to hinge less on the revenue print and more on the cadence of margin and cash conversion, areas where bullish analysts believe the company carries favorable asymmetry relative to expectations.
Comments